The results reported here provide insight into how dysregulated lipid metabolism in metastatic breast cancer cells contributes to specific steps in metastasis and thus highlight proteins such as FASN that could be targeted to minimize the negative effects of lipid-rich, metastatic breast cancer progression. This evidence concerns the gene FASN and breast carcinoma.